Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

23 mai 2018 08h00 HE | Source: Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals Provides a Pipeline Update

ENGLEWOOD CLIFFS, N.J., May 23, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents for...
15 mai 2018 09h00 HE | Source: Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals Presents Updated Positive Results from Phase 2 Trial of Bertilimumab in Bullous Pemphigoid

- Results from all subjects confirm excellent safety and tolerability and a large benefit across a variety of efficacy measures despite aggressive prednisone tapering - - Positive data support...
07 mai 2018 08h30 HE | Source: Immune Pharmaceuticals, Inc.

Immune Pharmaceuticals Provides Update on Plans for Oncology Subsidiary, Cytovia, Inc.

ENGLEWOOD CLIFFS, New Jersey, May 07, 2018 (GLOBE NEWSWIRE) -- Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) (“Immune” or the “Company”), a biopharmaceutical company developing novel therapeutic agents...